All Title Author
Keywords Abstract

Publish in OALib Journal
ISSN: 2333-9721
APC: Only $99
Paper Submission

Why Us? >>
- Open Access
- Peer-reviewed
- Rapid publication
- Lifetime hosting
- Free indexing service
- Free promotion service
- More...
- Search engine friendly

Archive of "Oncoscience".

ISSN Print: 2331-4737

ISSN Online:

Website: https://www.ncbi.nlm.nih.gov/pmc/journals/2609/

Share:




Go

EPAC mediates the dual role of cAMP signaling in melanoma

Carlos I. Rodriguez,Vijayasaradhi Setaluri

ZC3H12A Expression in Different Stages of Colorectal Cancer

Di Du,Jian Chen,John N. Weinstein,Liqing Yao,Pinghong Zhou,Tao Chen,Yuexin Liu

Liquid Biopsies Using Plasma Exosomal Nucleic Acids

Filip Janku,Lino M？hrmann

Direct Inhibition of β-catenin: A new strategy for colorectal cancer

Bob D. Brown,Marc Abrams,Shanthi Ganesh

Targeting primary cilia – associated signaling in glioblastoma: guided approach for drug development

Elena N. Pugacheva,Yuriy Loskutov

Genome atlas analysis based profiling of Akt pathway genes in the early and advanced human prostate cancer

Abdulrahman Alwhaibi,Ewan K. Cobran,Fei Gao,Payaningal R. Somanath,Ravindra Kolhe

CDK12 inactivation across solid tumors: an actionable genetic subtype

Catherine H. Marshall,Eddie L. Imada,Emmanuel S. Antonarakis,Luigi Marchionni,Zhuojun Tang

Localized RAS signaling drives cancer

Peter F. Johnson,Sandip K. Basu,Srikanta Basu

DNA methylation in senescence, aging and cancer

Hariharan Easwaran,Stephen B. Baylin,Wenbing Xie

Translating the role of PARP inhibitors in triple-negative breast cancer

Michèle Beniey,Saima Hassan,Takrima Haque

Still a hopeless case for personalized oncology? Pancreatic cancer revisited

Jens T. Siveke,Martin R. Sprick,Wilko Weichert

Suppression of vascular endothelial growth factor expression in breast cancer cells by microRNA-125b-mediated attenuation of serum amyloid A activating factor-1 level

Alpana Ray,Bimal K. Ray

Targeting MYC for triple-negative breast cancer treatment

Bradley A. Schulte,Gavin Y. Wang,Nancy Klauber-DeMore

Selective targeting of p53 gain-of-function mutants in cancer

Achuth Padmanabhan

Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer

Chloé Féral,Laetitia Seguin

BETter together: exploiting BRD4-functions in transcription to inform rational combinations

Fabio Savarese,Norbert Kraut

Poldip2 takes a central role in metabolic reprograming

Alejandra San Martin,Felipe Paredes,Izabela Suster

Curing cancer? Further along the new pH-centric road and paradigm

S. Harguindey,S. J. Reshkin,T. Koltai

Combating resistance to DNA damaging agents

Anthony Berdis,Jung-Suk Choi

Advances in biomarkers and treatment strategies for HPV-associated head and neck cancer

Cassie Pan,Natalia Issaeva,Wendell G. Yarbrough

Targeting p27 tyrosine phosphorylation as a modality to inhibit CDK4 and CDK2 and cause cell cycle arrest in breast cancer cells

Stacy W. Blain

KDM2B in papillomavirus-related cancer

Elektra Peta,Giulia Masi,Luisa Barzon

GPR50 in TGFβ signaling and breast cancer

Raise Ahmad,Ralf Jockers,Stefanie Wojciech

Efferocytosis and prostate cancer skeletal metastasis: implications for intervention

Hernan Roca,Laurie K. McCauley

Quantitative pharmacology in antibody-drug conjugate development: armed antibodies or targeted small molecules?

Eshita Khera,Greg M. Thurber,Ian Nessler

Targeting PIM kinases to oppose hypoxia-mediated therapeutic resistance

Noel A. Warfel,Shailender S. Chauhan

Re-thinking preclinical models of cancer metastasis

Jeremy S. Logue,Maria F. Ullo

Docetaxel increases the risk of severe infections in the treatment of non-small cell lung cancer: a meta-analysis

Guanming Jiang,Qingcheng Du,Silu Li,Yong Liu,Zunnan Huang

Macrophages as prognostic biomarkers in human melanoma

Alba Gutiérrez-Seijo,Paloma Sánchez-Mateos,Rafael Samaniego

Hemangioblast: origin of hemangioblastoma in von Hippel-Lindau (VHL) syndrome

Chi-Chao Chan,Herui Wang,Zhengping Zhuang

Coaching tumor-infiltrating CD8+ T cells to eat right

Hildegund CJ Ertl,Raj Kurupati

N-MYC regulation of DNA damage response in neuroendocrine prostate cancer: mechanistic insight and novel combination therapy approaches

Bo Liu,Likun Li,Timothy C. Thompson

Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment

Anoop P. Ayyappan,Brad A. Bryan,Dana C. Galván

Reply to: Biological role of miR-204 and miR-211 in melanoma (published in Oncoscience, Vol 5 (7-8), July 2018)

Joaquin Teixidó,Lola Alonso,Lucía Benito-Jardón,Marta Díaz-Martínez

Coaching tumor-infiltrating CD8+ T cells to eat right

Hildegund CJ Ertl,Ral Kurupati

Targeting protein myristoylation for the treatment of prostate cancer

Essilvo Sulejmani,Houjian Cai

Precision medicine meets the DNA damage response in pancreatic cancer

Alexander Kleger,Anett Illing,Johann Gout,Lukas Perkhofer,Pierre-Olivier Frappart

In quest for leukemia initiating cells in AML

Maria De Grandis,Michel Aurrand-Lions,Stéphane JC Mancini

Determinant factors for chronic kidney disease after partial nephrectomy

Diego Dallos,Giovanni E. Cacciamani,Heilen Bravo,Luis G. Medina,Marcos Arias,Oscar D. Martín,Raul G. Carlini,Yesica Quiroz

The Hippo pathway and cancer immunity: friend or foe?

Helena J Janse van Rensburg,Xiaolong Yang

BFL-1 expression determines the efficacy of venetoclax in MYC+/BCL2+ double hit lymphoma

Anna Esteve-Arenys,Gael Roue

Targeting parallel bypass signaling to combat adaptive resistance to BRAF inhibition in colorectal cancer

Chenxi Gao,Jing Hu

VEGF signaling in acute leukemia: mitochondrial connections

Sandrina Nóbrega-Pereira,Sérgio Dias

Combination drug development in BRAF mutant colorectal cancer

Michael Lam,Shubham Pant,Timothy A. Yap

Targeting focal adhesion kinase overcomes erlotinib resistance in smoke induced lung cancer by altering phosphorylation of epidermal growth factor receptor

Aditi Chatterjee,Akhilesh Pandey,Alex Zhavoronkov,Aneesha Radhakrishnan,Annapoorni Rangarajan,Artem V. Artemov,Arun H. Patil,Daria Gaykalova,David Sidransky,Evgeny Izumchenko,Harsha Gowda,Hitendra S. Solanki,Ivan V. Ozerov,Jayshree Advani,Nandini A. Sahasrabuddhe,Nazia Syed,Niraj Babu,Premendu Prakash Mathur,Rachana Sathyendran,Remya Raja,T.S. Keshava Prasad,Tejaswini Subbannayya,Vinuth N. Puttamallesh,Vishalakshi Nanjappa,Xiaofei Chang

Re-thinking the preclinical development of GBM therapeutics

David A. Cheresh,Sara M. Weis,érika Cosset

Programming a serial killer: CAR T cells form non-classical immune synapses

Alexander J Davenport,Misty R Jenkins

Hedgehog in prostate cancer explained

Na Li,Ralph Buttyan,Shabnam Massah

High-dimensional regression analysis links magnetic resonance imaging features and protein expression and signaling pathway alterations in breast invasive carcinoma

Anindya Bhadra,Arvind Rao,Basak Dogan,Elizabeth Morris,Elizabeth S. Burnside,Elizabeth Sutton,Emerlinda Bonaccio,Gary J. Whitman,Jose Net,Kathy Brandt,Margarita Zuley,Marie Ganott,Michael Lehrer,Sathvik Aithala,TCGA Breast Phenotype Research Group,Visweswaran Ravikumar,Youyun Zheng

Germline genetic testing in prostate cancer – further enrichment in variant histologies?

Emmanuel S. Antonarakis,Mark C. Markowski

Go




©2008-2020 OALib, Inc | Public user content licensed CC-BY 4.0 unless otherwise specified. OALib ISSN Online: 2333-9721 OALib ISSN Print: 2333-9705